• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session

    10/3/22 12:27:22 PM ET
    $AA
    $ACOR
    $ADTX
    $ANEB
    Aluminum
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AA alert in real time by email

    Gainers

    • LogicBio Therapeutics, Inc. (NASDAQ:LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
    • FedNat Holding Company (NASDAQ:FNHC) jumped 223% to $0.3725 after dipping around 28% on Friday.
    • FingerMotion, Inc. (NASDAQ:FNGR) shares gained 63.3% to $5.50 after the stock rose more than 80% Friday.
    • Avenue Therapeutics, Inc. (NASDAQ:ATXI) gained 47.1% to $14.83.
    • Myovant Sciences Ltd. (NYSE:MYOV) shares gained 36% to $24.43 after the company received an acquisition offer from Sumitovant Biopharma and Sumitormo Pharma to acquire the company for $22.75 per share in cash.
    • Wearable Devices Ltd. (NASDAQ:WLDS) climbed 33% to $1.1701 after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.
    • Color Star Technology Co., Ltd. (NASDAQ:CSCW) rose 32% to $1.56.
    • Viasat, Inc. (NASDAQ:VSAT) gained 27.3% to $38.47 after the company announced it entered into a definitive agreement to sell its Link 16 Tactical Data Links business to L3Harris Technologies for $1.96 billion.
    • Flexible Solutions International, Inc. (NYSE:FSI) rose 25.7% to $2.0736. FSI reported termination of merger with Lygos Inc.
    • Bionomics Limited (NASDAQ:BNOX) gained 24.4% to $7.79.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) jumped 20.9% to $3.3861. Anebulo Pharmaceuticals recently announced interim data from the first two cohorts of Part B of its ongoing Phase 2 trial of ANEB-001 for acute cannabinoid intoxication (ACI).
    • Versus Systems Inc. (NASDAQ:VS) gained 20.5% to $0.2254.
    • LiveWire Group, Inc. (NYSE:LVWR) rose 20.3% to $8.64.
    • Companhia de Saneamento Básico do Estado de São Paulo – SABESP (NYSE:SBS) gained 20.2% to $10.95.
    • Kuke Music Holding Limited (NYSE:KUKE) jumped 19.9% to $0.5645.
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) gained 19.4% to $0.2030. Tenax Therapeutics, last month, said it is evaluating alternative strategic paths.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) climbed 18.5% to $3.4876 after the company announced the FDA granted Fast Track designation for sapanisertib for the treatment of NRF2-mutated squamous lung cancer.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) rose 16.7% to $0.3490 after gaining 8% on Friday.
    • QualTek Services Inc. (NASDAQ:QTEK) gained 16.3% to $2.33.
    • Freight Technologies, Inc. (NASDAQ:FRGT) climbed 15.6% to $0.59.
    • New Gold Inc. (NYSE:NGD) gained 14.5% to $1.0087. RBC Capital upgraded New Gold from Sector Perform to Outperform and raised the price target from $1 to $1.25.
    • LiveWire Group, Inc. (NYSE:LVWR) surged 13.7% to $8.17.
    • InterDigital, Inc. (NASDAQ:IDCC) jumped 13.8% to $46.02 after the company raised its Q3 sales guidance and entered into a patent license agreement with a major technology company.
    • Coeur Mining, Inc. (NYSE:CDE) gained 13.7% to $3.89.
    • Vertiv Holdings Co (NYSE:VRT) jumped 13% to $11.02 Vertiv Holdings Co Chief Executive Officer Rob Johnson will retire from his position due to health reasons, effective December 31, 2022.
    • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) rose 12.8% to $23.00 after dropping around 40% on Friday.
    • Mesoblast Limited (NASDAQ:MESO) jumped 12% to $2.85.
    • Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR) rose 11.9% to $13.81.
    • Mondee Holdings, Inc. (NASDAQ:MOND) fell 11.7% to $8.73.
    • Aditxt, Inc. (NASDAQ:ADTX) gained 10% to $3.70.
    • Kosmos Energy Ltd. (NYSE:KOS) jumped 9.3% to $5.65. Shares of several oil stocks traded higher amid an increase in the price of oil as OPEC+ is rumored to be considering a ~1M barrel per day oil production cut.
    • Alcoa Corporation (NYSE:AA) gained 8.5% to $36.52.
    • United States Steel Corporation (NYSE:X) jumped 6% to $19.20.


    Losers

    • Blue Apron Holdings, Inc. (NYSE:APRN) dropped 35% to $3.76 after the company announced an equity distribution agreement allowing the company to sell up to $15 million of stock.
    • Clene Inc. (NASDAQ:CLNN) shares dipped 31.4% to $1.92 after the company released topline results from the Healey ALS Platform trial of CNM-Au8, an investigational gold nanocrystal suspension, in participants with amyotrophic lateral sclerosis (ALS).
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 31.2% to $2.0812. American Virtual Cloud Technologies, on Friday, announced the intent to effect a reverse stock split.
    • Timber Pharmaceuticals, Inc. (NYSE:TMBR) fell 23.3% to $0.0920. Timber Pharmaceuticals reported a $1.3 million registered direct offering.
    • Belite Bio, Inc (NASDAQ:BLTE) dropped 20.8% to $26.80. Belite Bio presented 12-month interim results of LBS-008 Phase 1b/2 study in adolescent Stargardt disease at the AAO Annual Meeting 2022.
    • Waldencast plc (NASDAQ:WALD) dropped 15% to $8.50.
    • FaZe Holdings Inc. (NASDAQ:FAZE) declined 15% to $8.23.
    • SHF Holdings, Inc. (NASDAQ:SHFS) fell 14% to $5.96 after dropping 20% on Friday.
    • Takung Art Co., Ltd. (NASDAQ:TKAT) declined 14% to $0.8949.
    • Lilium N.V. (NASDAQ:LILM) dropped 12.9% to $1.9850. Lilium recently announced partnership with GlobeAir.
    • Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) fell 12.1% to $60.03.
    • Aura Biosciences, Inc. (NASDAQ:AURA) fell 11.7% to $16.00. Aura Biosciences announced interim Phase 2 data evaluating suprachoroidal administration of belzupacap sarotalocan for the first-line treatment of patients with early-stage choroidal melanoma presented at the AAO 2022.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) dropped 11.5% to $7.78.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) fell 11% to $0.89.
    • Hippo Holdings Inc. (NYSE:HIPO) declined 9.7% to $16.72.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) dropped 8.2% to $0.0991. Maxim Group recently downgraded Kintara Therapeutics from Buy to Hold.
    • Remitly Global, Inc. (NASDAQ:RELY) dipped 7.8% to $10.25.
    • SAI.TECH Global Corporation (NASDAQ:SAI) fell 7.3% to $3.0050 after jumping 43% on Friday.
    • Tesla, Inc. (NASDAQ:TSLA) shares fell 7.2% to $246.09 after the company reported third-quarter vehicle deliveries below Wall Street expectations. Tesla said it produced 365,923 vehicles in the quarter and delivered 343,830.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ACOR
    $ADTX
    $ANEB

    CompanyDatePrice TargetRatingAnalyst
    Tyra Biosciences Inc.
    $TYRA
    2/24/2026Overweight
    Cantor Fitzgerald
    Coeur Mining Inc.
    $CDE
    2/20/2026Buy → Hold
    Canaccord Genuity
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tyra Biosciences Inc.
    $TYRA
    2/10/2026Outperform
    William Blair
    Remitly Global Inc.
    $RELY
    2/10/2026$18.00Buy
    BofA Securities
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    More analyst ratings

    $AA
    $ACOR
    $ADTX
    $ANEB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilson-Thompson Kathleen exercised 40,000 shares at a strike of $14.99 and sold $10,692,814 worth of shares (25,731 units at $415.56), increasing direct ownership by 264% to 19,669 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    2/27/26 7:00:21 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    CEO Spinnaker Ostergaard Torben sold $18,266 worth of shares (600 units at $30.44), decreasing direct ownership by 1% to 46,094 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/27/26 4:58:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Chief Product and Tech Officer Sinha Ankur converted options into 66,581 shares and covered exercise/tax liability with 17,872 shares, increasing direct ownership by 165% to 1,189,860 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    2/27/26 4:41:18 PM ET
    $RELY
    Real Estate

    $AA
    $ACOR
    $ADTX
    $ANEB
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ACOR
    $ADTX
    $ANEB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Tyra Biosciences

    Cantor Fitzgerald initiated coverage of Tyra Biosciences with a rating of Overweight

    2/24/26 7:56:45 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Coeur Mining downgraded by Canaccord Genuity

    Canaccord Genuity downgraded Coeur Mining from Buy to Hold

    2/20/26 8:21:45 AM ET
    $CDE
    Precious Metals
    Basic Materials

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AA
    $ACOR
    $ADTX
    $ANEB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bobbili Raja bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:42:27 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Large owner Abrams Capital Management, L.P. bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:37:36 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Abrams David C bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:36:32 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AA
    $ACOR
    $ADTX
    $ANEB
    SEC Filings

    View All

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $AA
    $ACOR
    $ADTX
    $ANEB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kosmos Energy Announces Fourth Quarter And Full Year 2025 Results

    DALLAS, March 02, 2026 (GLOBE NEWSWIRE) -- Kosmos Energy Ltd. ("Kosmos" or the "Company") (NYSE/LSE: KOS) announced today its financial and operating results for the fourth quarter of 2025. For the quarter, the Company generated a net loss of $377 million, or $0.79 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net loss(1) of $78 million, or $0.16 per diluted share for the fourth quarter of 2025. FOURTH QUARTER 2025 AND POST QUARTER END HIGHLIGHTS Zero lost-time injuries or total recordable injuries in 2025Net Production(2): ~67,900 barrels of oil equivalent per day (boepd), up ~4% versus third quarter 2025,

    3/2/26 2:00:00 AM ET
    $KOS
    Oil & Gas Production
    Energy

    Space42 and Viasat to Share Progress on Equatys at Mobile World Congress

    BARCELONA, Spain, March 02, 2026 (GLOBE NEWSWIRE) -- Space42, the UAE-based AI-powered SpaceTech company, and Viasat, Inc., a global leader in satellite communications, will discuss continued progress toward their planned direct-to-device (D2D) infrastructure and offer an early look at the priorities for Equatys, the companies' forthcoming joint entity, during a co-hosted program at Mobile World Congress in Barcelona this week. The program marks the first public showcase of Equatys' technical direction and commercial vision, reflecting its ambition to accelerate global D2D adoption.   This event brings together policymakers, regulators, and industry leaders to explore how competition, resi

    3/2/26 1:00:00 AM ET
    $VSAT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), today announced Schweiger Dermatology as a key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program. Schweiger will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple trials and evaluation programs. "This partnership with Obagi makes perfect sense for us. They're taking a thoughtful, evidence-based approach to introducing this innovative injectable, and we

    2/27/26 8:33:00 AM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary

    $AA
    $ACOR
    $ADTX
    $ANEB
    Leadership Updates

    Live Leadership Updates

    View All

    Remitly Appoints Sebastian J. Gunningham as Chief Executive Officer

    SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company") today announced the appointment of Sebastian J. Gunningham as Chief Executive Officer ("CEO") and member of the Board of Directors (the "Board"), effective February 19, 2026. Mr. Gunningham succeeds Co-Founder Matt Oppenheimer, who decided to transition the role of CEO to a new leader after nearly 15 years of driving transformative growth that built Remitly into one of the world's leading networks for digital and physical money movement. Mr. Oppenheimer will continue to serve as Chairman of the Board. Sebastian Gunningham brings decades of global leadership and product innovation exp

    2/18/26 4:05:00 PM ET
    $RELY
    Real Estate

    Remitly Reports Fourth Quarter and Full Year 2025 Results Above Outlook

    Reported first full year of GAAP profitabilityRecord fourth quarter results: revenue of $442.2 million, net income of $41.2 million, and Adjusted EBITDA of $88.6 million SEATTLE, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of financial services that transcend borders, reported results for the fourth quarter and full year ended December 31, 2025. "We ended 2025 with very strong results, exceeding our guidance for both revenue and Adjusted EBITDA," said Matt Oppenheimer, co-founder and Chief Executive Officer, Remitly. "These exceptional results and the strategic accomplishments realized in 2025 create the right moment to accelerate execution wi

    2/18/26 4:04:00 PM ET
    $RELY
    Real Estate

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    $AA
    $ACOR
    $ADTX
    $ANEB
    Financials

    Live finance-specific insights

    View All

    Kosmos Energy Announces Fourth Quarter And Full Year 2025 Results

    DALLAS, March 02, 2026 (GLOBE NEWSWIRE) -- Kosmos Energy Ltd. ("Kosmos" or the "Company") (NYSE/LSE: KOS) announced today its financial and operating results for the fourth quarter of 2025. For the quarter, the Company generated a net loss of $377 million, or $0.79 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net loss(1) of $78 million, or $0.16 per diluted share for the fourth quarter of 2025. FOURTH QUARTER 2025 AND POST QUARTER END HIGHLIGHTS Zero lost-time injuries or total recordable injuries in 2025Net Production(2): ~67,900 barrels of oil equivalent per day (boepd), up ~4% versus third quarter 2025,

    3/2/26 2:00:00 AM ET
    $KOS
    Oil & Gas Production
    Energy

    Alcoa Corporation Declares Quarterly Cash Dividend

    Alcoa Corporation (NYSE:AA, ASX: AAI)) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of the Company's common stock, to be paid on March 26, 2026 to stockholders of record as of the close of business on March 10, 2026. About Alcoa Corporation Alcoa is a global industry leader in bauxite, alumina and aluminum products with a vision to build a legacy of excellence for future generations. With a values-based approach that encompasses integrity, operating excellence, care for people, and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital

    2/26/26 5:25:00 PM ET
    $AA
    Aluminum
    Industrials

    Hippo Reports Fourth Quarter 2025 Financial Results

    SAN JOSE, Calif., Feb. 25, 2026 /PRNewswire/ -- Hippo Holdings Inc. (NYSE:HIPO), a technology-native insurance platform driving growth across owned and partner MGAs, announced its consolidated financial results including diluted earnings per share of $0.23 and diluted adjusted earnings per share of $0.67 for the quarter ended December 31, 2025. Fourth Quarter HighlightsGross Written Premium increased 40% to $288 million over 4Q24Net Written Premium increased 23% to $97 million over 4Q24Net Income attributable to Hippo of $6 million compared to $44 million in 4Q24Adjusted Net Inc

    2/25/26 7:00:00 AM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    $AA
    $ACOR
    $ADTX
    $ANEB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mesoblast Limited

    SC 13G/A - MESOBLAST LTD (0001345099) (Subject)

    12/16/24 12:08:07 PM ET
    $MESO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    12/6/24 9:30:49 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care